Skip to main content
Top
Published in:

Open Access 01-12-2024 | Bevacizumab | Research

The macular microvascular changes in children with a history of retinopathy of prematurity treated with intravitreal Bevacizumab injection using optical coherence tomography angiography: a retrospective cohort

Authors: Amir Eftekhari Milani, Mohammad Hosein Ahoor, Fatemeh Etemad, Banafsheh Kharrazi Ghadim, Amin Arasteh

Published in: BMC Ophthalmology | Issue 1/2024

Login to get access

Abstract

Objective

Our study aims to evaluate and compare the macular microvascular condition of the intravitreal Bevacizumab (IVB)-treated retinopathy of prematurity (ROP) cases to the preterm cases without ROP and spontaneously regressed ROPs.

Methods

It is a retrospective cohort of 50 premature neonates visited from 2016 to 2017 for ROP screening in Nikookari Eye Hospital and recalled for re-evaluation in 2022. These patients were classified into three groups based on their medical documents: 1. Preterm cases without ROP (PT), 2. Spontaneously regressed ROPs (SR), and 3. IVB-treated ROPs (IVB). All the included cases underwent a thorough ophthalmic exam, cyclo-refraction, Best-corrected visual acuity (BCVA) assessment, and macular optical coherence tomography angiography (OCTA). The foveal thickness, foveal avascular zone (FAZ) area, foveal, parafoveal, and perifoveal vascular density (VD) were evaluated as the quantitative variables.

Results

Twenty-five male and 25 female cases with a median age of 5.0 entered the study. Twenty-six eyes were evaluated in the PT group, 50 in the SR group, and 24 in the IVB group. The SR group consisted of 25 zone-2 and 25 zone-3 ROPs. In comparison, the IVB group consisted of 9 zone-1 and 15 zone-2 ROPs (p: < 001). Also, zone-2 cases were more advanced in the IVB group. The IVB-treated eyes demonstrated a significantly higher foveal superficial capillary plexus (SCP) VD than the others (28.5% vs. 23.1 and 22.9, respectively, in PT and SR, p:0.008). However, the parafoveal deep capillary plexus (DCP) VD was lower than the PT cases (48.5% vs. 53.4, p:0.034). The FAZ area was also smaller than the PT cases (0.113 vs.0.219 mm2, p:0.032). The FAZ area was significantly positively correlated with the foveal SCP and DCP VD and negatively correlated with parafoveal DCP VD (CC: -0.770, -0.719, 0.377, respectively, p: < 0.001).

Conclusion

In the long term, although the IVB-treated ROP cases experience an excellent visual outcome comparable to those without ROP, they may show some macular microvascular changes. These changes might be related to the effect of IVB or the nature of more advanced stages of ROP.

Graphical Abstract

Literature
1.
2.
go back to reference Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63:618–37.CrossRefPubMedPubMedCentral Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63:618–37.CrossRefPubMedPubMedCentral
3.
go back to reference Milani AE, Arasteh A, Saeedi-Maleki Z, Niyousha MR, Sahebazamani MA, Brumandpur F. Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection. BMC Ophthalmol. 2024;24:265.CrossRefPubMedPubMedCentral Milani AE, Arasteh A, Saeedi-Maleki Z, Niyousha MR, Sahebazamani MA, Brumandpur F. Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection. BMC Ophthalmol. 2024;24:265.CrossRefPubMedPubMedCentral
4.
go back to reference Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA. Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog Retin Eye Res. 2018;62:77–119.CrossRefPubMed Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA. Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog Retin Eye Res. 2018;62:77–119.CrossRefPubMed
5.
go back to reference Milani AE, Javani B, Ahoor M, Shahshahani MA, Farhadi F. Foveal and Retinal Nerve Fiber Layer thickness in children with a history of retinopathy of prematurity treated With Bevacizumab: a cross-sectional study. Crescent J Med Biol Sci. 2023;10:169–75. Milani AE, Javani B, Ahoor M, Shahshahani MA, Farhadi F. Foveal and Retinal Nerve Fiber Layer thickness in children with a history of retinopathy of prematurity treated With Bevacizumab: a cross-sectional study. Crescent J Med Biol Sci. 2023;10:169–75.
6.
go back to reference Sternfeld A, Rahmani S, Rossen JL, Zhang DL, Li YD, Quan VL, et al. Long-term retinal vasculature abnormalities following intravitreal Bevacizumab for retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2022;260:1915–21.CrossRefPubMed Sternfeld A, Rahmani S, Rossen JL, Zhang DL, Li YD, Quan VL, et al. Long-term retinal vasculature abnormalities following intravitreal Bevacizumab for retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2022;260:1915–21.CrossRefPubMed
7.
go back to reference Lee G-I, Park K-A, Oh SY, Kim SJ. Retinal and peripapillary vascular deformations in prematurely born children aged 4–12 years with a history of retinopathy of prematurity. Sci Rep. 2023;13:3130.CrossRefPubMedPubMedCentral Lee G-I, Park K-A, Oh SY, Kim SJ. Retinal and peripapillary vascular deformations in prematurely born children aged 4–12 years with a history of retinopathy of prematurity. Sci Rep. 2023;13:3130.CrossRefPubMedPubMedCentral
8.
go back to reference Kılıçarslan O, Akar S, Yılmaz Çebi A, Hagverdiyeva S, Arvas S. Evaluation of macular microvascular structure with optical coherence tomography angiography in children with history of treatment for retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2023;261:651–7.CrossRefPubMed Kılıçarslan O, Akar S, Yılmaz Çebi A, Hagverdiyeva S, Arvas S. Evaluation of macular microvascular structure with optical coherence tomography angiography in children with history of treatment for retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2023;261:651–7.CrossRefPubMed
9.
go back to reference Carroll L, Owen LA. Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions. Explor Med. 2020;1:4–26.CrossRefPubMedPubMedCentral Carroll L, Owen LA. Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions. Explor Med. 2020;1:4–26.CrossRefPubMedPubMedCentral
10.
go back to reference Isaac M, Mireskandari K, Tehrani N. Treatment of type 1 retinopathy of prematurity with Bevacizumab versus laser. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus. 2015;19:140–4. Isaac M, Mireskandari K, Tehrani N. Treatment of type 1 retinopathy of prematurity with Bevacizumab versus laser. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus. 2015;19:140–4.
11.
go back to reference Filek R, Hooper P, Sheidow TG, Gonder J, Chakrabarti S, Hutnik CM. Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients. Clin Ophthalmol. 2019;13:1087–96.CrossRefPubMedPubMedCentral Filek R, Hooper P, Sheidow TG, Gonder J, Chakrabarti S, Hutnik CM. Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients. Clin Ophthalmol. 2019;13:1087–96.CrossRefPubMedPubMedCentral
12.
go back to reference Nicolai M, Franceschi A, De Turris S, Rosati A, Pirani V, Mariotti C. Papillary vessel density changes after intravitreal anti-VEGF injections in hypertensive patients with central retinal vein occlusion: an angio-OCT study. J Clin Med. 2019;8:1636.CrossRefPubMedPubMedCentral Nicolai M, Franceschi A, De Turris S, Rosati A, Pirani V, Mariotti C. Papillary vessel density changes after intravitreal anti-VEGF injections in hypertensive patients with central retinal vein occlusion: an angio-OCT study. J Clin Med. 2019;8:1636.CrossRefPubMedPubMedCentral
13.
go back to reference Sorour OA, Sabrosa AS, Yasin Alibhai A, Arya M, Ishibazawa A, Witkin AJ, et al. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Int Ophthalmol. 2019;39:2361–71.CrossRefPubMed Sorour OA, Sabrosa AS, Yasin Alibhai A, Arya M, Ishibazawa A, Witkin AJ, et al. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Int Ophthalmol. 2019;39:2361–71.CrossRefPubMed
14.
go back to reference Cennamo G, Montorio D, D’Alessandro A, Napolitano P, D’Andrea L, Tranfa F. Prospective study of vessel density by optical coherence tomography angiography after intravitreal Bevacizumab in exudative age-related macular degeneration. Ophthalmol Ther. 2020;9:77–85.CrossRefPubMed Cennamo G, Montorio D, D’Alessandro A, Napolitano P, D’Andrea L, Tranfa F. Prospective study of vessel density by optical coherence tomography angiography after intravitreal Bevacizumab in exudative age-related macular degeneration. Ophthalmol Ther. 2020;9:77–85.CrossRefPubMed
15.
go back to reference Korobelnik J-F, Gaucher D, Baillif S, Creuzot-Garcher C, Kodjikian L, Weber M. Optical coherence tomography angiography in diabetic macular edema treated with intravitreal aflibercept: a 48-week observational study (the DOCTA study). Ophthalmologica. 2023;246:71–80.CrossRefPubMed Korobelnik J-F, Gaucher D, Baillif S, Creuzot-Garcher C, Kodjikian L, Weber M. Optical coherence tomography angiography in diabetic macular edema treated with intravitreal aflibercept: a 48-week observational study (the DOCTA study). Ophthalmologica. 2023;246:71–80.CrossRefPubMed
16.
go back to reference Santamaría J, Caminal JM, Cobos E, Biarnes M, Rodriguez-Leor R, Morwani R, et al. Correlation between topographic vessel density and retinal thickness changes in patients with diabetic macular edema treated with anti-VEGF therapy: is it a suitable OCTA biomarker? J Pers Med. 2023;13:1718.CrossRefPubMedPubMedCentral Santamaría J, Caminal JM, Cobos E, Biarnes M, Rodriguez-Leor R, Morwani R, et al. Correlation between topographic vessel density and retinal thickness changes in patients with diabetic macular edema treated with anti-VEGF therapy: is it a suitable OCTA biomarker? J Pers Med. 2023;13:1718.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Chen Y-C, Chen Y-T, Chen S-N. Foveal microvascular anomalies on optical coherence tomography angiography and the correlation with foveal thickness and visual acuity in retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2019;257:23–30.CrossRefPubMed Chen Y-C, Chen Y-T, Chen S-N. Foveal microvascular anomalies on optical coherence tomography angiography and the correlation with foveal thickness and visual acuity in retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2019;257:23–30.CrossRefPubMed
19.
go back to reference Chen Y-C, Chen S-N. Foveal microvasculature, refractive errors, optical biometry and their correlations in school-aged children with retinopathy of prematurity after intravitreal antivascular endothelial growth factors or laser photocoagulation. Br J Ophthalmol. 2020;104:691–6.CrossRefPubMed Chen Y-C, Chen S-N. Foveal microvasculature, refractive errors, optical biometry and their correlations in school-aged children with retinopathy of prematurity after intravitreal antivascular endothelial growth factors or laser photocoagulation. Br J Ophthalmol. 2020;104:691–6.CrossRefPubMed
20.
go back to reference Sugioka K, Saito A, Kusaka S, Kuniyoshi K, Shimomura Y. Identification of vitreous proteins in retinopathy of prematurity. Biochem Biophys Res Commun. 2017;488:483–8.CrossRefPubMed Sugioka K, Saito A, Kusaka S, Kuniyoshi K, Shimomura Y. Identification of vitreous proteins in retinopathy of prematurity. Biochem Biophys Res Commun. 2017;488:483–8.CrossRefPubMed
21.
go back to reference Chan W-M, Lai TYY, Chan K-P, Li H, Liu DTL, Lam DSC, et al. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina. 2008;28:1308.CrossRefPubMed Chan W-M, Lai TYY, Chan K-P, Li H, Liu DTL, Lam DSC, et al. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina. 2008;28:1308.CrossRefPubMed
22.
go back to reference Provis JM, Dubis AM, Maddess T, Carroll J. Adaptation of the central retina for high acuity vision: Cones, the fovea and the avascular zone. Prog Retin Eye Res. 2013;35:63–81.CrossRefPubMedPubMedCentral Provis JM, Dubis AM, Maddess T, Carroll J. Adaptation of the central retina for high acuity vision: Cones, the fovea and the avascular zone. Prog Retin Eye Res. 2013;35:63–81.CrossRefPubMedPubMedCentral
23.
go back to reference Zhou K, Song S, Legocki A, Cheng Y, Ding L, Rezaei KA, et al. Quantitative handheld swept-source optical coherence tomography angiography in awake preterm and full-term infants. Transl Vis Sci Technol. 2020;9:19.CrossRefPubMedPubMedCentral Zhou K, Song S, Legocki A, Cheng Y, Ding L, Rezaei KA, et al. Quantitative handheld swept-source optical coherence tomography angiography in awake preterm and full-term infants. Transl Vis Sci Technol. 2020;9:19.CrossRefPubMedPubMedCentral
Metadata
Title
The macular microvascular changes in children with a history of retinopathy of prematurity treated with intravitreal Bevacizumab injection using optical coherence tomography angiography: a retrospective cohort
Authors
Amir Eftekhari Milani
Mohammad Hosein Ahoor
Fatemeh Etemad
Banafsheh Kharrazi Ghadim
Amin Arasteh
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2024
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-024-03773-3